Top Markets
Coin of the day
Allena Pharmaceuticals, Inc. Allena Pharmaceuticals, Inc.

Allena Pharmaceuticals, Inc.

ALNAQ
Peringkat dalam Saham #42825
Operating as a biopharmaceutical firm, Allena Pharmaceuticals, Inc. focuses on... Operating as a biopharmaceutical firm, Allena Pharmaceuticals, Inc. focuses on unearthing, developing, and marketing oral enzyme therapies. These treatments are devised to assist patients in the United States afflicted by uncommon and serious metabolic as well as renal conditions. Central to its pipeline is ALLN-346, an innovative enzyme designed to degrade urate, targeting hyperuricemia and gout in individuals with advanced chronic kidney disease. The company, which commenced operations in 2011 and has its main office in Newton, Massachusetts, made headlines on September 2, 2022, by seeking voluntary reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Harga Saham
$0.000001
Terakhir disinkronkan: 2023-12-13
Kapitalisasi Pasar
$23.51
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Allena Pharmaceuticals, Inc. (ALNAQ)

Kategori

Riwayat hasil dividen untuk Allena Pharmaceuticals, Inc. (ALNAQ)
Hasil dividen (TTM) dari Allena Pharmaceuticals, Inc. (simbol saham: ALNAQ) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk Allena Pharmaceuticals, Inc. (ALNAQ) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing